# Contact MD PT-141: Editorial Corrections and Source Queries

> Contact MD PT-141, an independent editorial digest of the PT-141 (bremelanotide) research literature. For corrections and source questions only — not a clinic, not medical advice, no products sold.

For corrections, citation questions, and editorial feedback on our PT-141 summaries.

## Reach the editors

MD PT-141 is an independent editorial digest of the **PT-141** (bremelanotide) research literature. Use the form below for editorial matters: a citation that needs correcting, a study we should add, a place where the plain-English summary could be clearer, or a factual error in how we have described the record. We read every message about accuracy and sourcing.

We cannot help with anything clinical. This site does not provide medical advice, diagnosis, dosing guidance, or treatment, and it does not sell, supply, or source any product. Questions about whether a compound is right for a person, or where to obtain it, are outside what an editorial project can or should answer — those belong with a qualified healthcare professional.

## What to expect

Corrections that are well-sourced get folded into the relevant page, and we will note material changes. We do not respond to requests to buy, sell, or locate PT-141, to questions seeking a personal dose or protocol, or to outreach asking us to host promotional links. The site's value is its accuracy and its citations, and the inbox exists to protect that. For the underlying sources behind any claim, the [references](/references) page lists them with DOIs and PubMed links.

---

A clinician's measured read of the bremelanotide record — the confirmed trial findings raised plainly, the tolerability and contraindication facts pressed in first, and the unverified field reports kept off to one side; no clinic behind the surface and nothing here dosed, dispensed, or sold.